Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Directly observed treatment for multidrug-resistant tuberculosis: an economic evaluation in the United States of America and South Africa.
Wilton, P; SMITH, RD; Coast, J; Millar, M; Karcher, A;
2001
The international journal of tuberculosis and lung disease, (2001).5 12
Changing the first line drug for malaria treatment--cost-effectiveness analysis with highly uncertain inter-temporal trade-offs.
GOODMAN, CA; Coleman, PG; MILLS, AJ;
2001
Health economics, (2001).10 8 10.1002/hec.621.
Antimalarial Chemotherapy: Mechanisms of Action, Resistance and New Directions in Drug Discovery.
CROFT, S;
2001
Drug discovery today, (2001).6 22 10.1016/s1359-6446(01)02035-9.
Monitoring drug resistance in leishmaniasis.
CROFT, SL;
2001
Tropical medicine & international health, (2001).6 11 10.1046/j.1365-3156.2001.00754.x.
Plasmodium falciparum in Kenya: high prevalence of drug-resistance-associated polymorphisms in hospital admissions with severe malaria in an epidemic area.
Omar, SA; Adagu, IS; Gump, DW; Ndaru, NP; WARHURST, DC;
2001
Annals of tropical medicine and parasitology, (2001).95 7 10.1080/00034980120103234.
New developments: chloroquine-resistance in Plasmodium falciparum.
WARHURST, D;
2001
Drug resistance updates, (2001).4 3 10.1054/drup.2001.0194.
In vitro and in vivo activities of aminoadamantane and aminoalkylcyclohexane derivatives against Trypanosoma brucei.
KELLY, JM; Quack, G; MILES, MM;
2001
Antimicrobial agents and chemotherapy, (2001).45 5 10.1128/AAC.45.5.1360-1366.2001.
A molecular marker for chloroquine-resistant falciparum malaria.
WARHURST, DC;
2001
The New England journal of medicine, (2001).344 4 10.1056/NEJM200101253440411.